Lumenis Ltd.
Lumenis Ltd. is the global leader in medical and aesthetic lasers and light-based technology. LM Partners L.P. is a limited partnership established for the sole purpose of investing in Lumenis. D Partners II together with Ofer High Tech (an affiliate of the Ofer Brother Group) have organizing and led a group of investors to make an investment of $150 million in Lumenis in December 2006.
Archimedes Global Ltd.
Archimedes Global Ltd. (“AGL”) – a new venture which will invest and seek out investments in health insurance businesses worldwide. Headquartered in Tel Aviv, AGL is being formed by a prominent manager – Mr. Yaron Inbar- who has extensive experience in the health insurance sector.
Eyeblaster, Inc.
Eyeblaster is a global leader in rich media ad technology and a worldwide provider of unified digital marketing solutions. Eyeblaster provides interactive agencies, advertisers and publishers the first single solution to create, deliver and manage all forms of digital advertising through one powerful web dashboard.
Peninsula Financial Ltd.
Peninsula is an independent factoring company that provides cash flow solutions for expanding Israeli businesses. Peninsula's aim is to become a leading non-bank commercial finance company.
iDigital
The official distributor of Apple products in Israel and the PA territory. iDigital was established in October 2007 with a vision to lead the experience of the digital lifestyle in Israel.
AngioSlide Ltd.
AngioSlide Ltd. is an Israeli medical device company targeting the market of Cardiac Surgery. Vascular balloon dilatation (angioplasty) is a common medical procedure utilizing a catheter with a dilatation balloon in an attempt to dilate stenotic vessels, commonly followed by stenting of the vessel to reduce the rate of restenosis.
NanoPass Technologies Ltd.
NanoPass is devoted to the development of unique and independent drug-device combinations for shallow dermal delivery of vaccines and therapeutics.
EndoCross Ltd.
EndoCross is developing the next generation of chronic total occlusions (CTO) crossing devices, allowing quick and safe crossing of CTO in peripheral and coronary vessels.
PainReform
PainReform is a specialty pharmaceutical company that develops products for the treatment of nociceptive pain. Focused on reformulations of established pain drugs, PainReform applies unique technologies to enhance efficacy, reduce adverse effects and increase convenience.
